The company name joins the words oncology and data, and the product lines carry that through under an ON prefix. ON.ClinicalDataView reports physician-level treatment and prescribing behavior; Alerts sends daily or weekly notifications keyed to triggers such as diagnosis, treatment or reimbursement events; ON.Insights delivers market size analysis, forecasting, competitive positioning, patient journey tracking and reimbursement dynamics; and ON.Dispensing rounds out the commercial set. For health economics and research groups, ON.Journey supplies a standardized, research-ready dataset merging iKnowMed records with claims, spanning 13 solid and hematologic tumor types and more than 150 oncology-specific data elements from diagnosis through treatment to outcomes, so cohorts need not be rebuilt as questions change. ON.Multiomics reaches into translational work, linking molecular profiling from Caris Life Sciences with longitudinal clinical records: whole exome and whole transcriptome sequencing applied consistently across patients, immunohistochemistry outputs across more than 25 biomarkers, digitized H&E pathology, access to raw molecular files for custom analysis, and over 1,000 curated EHR variables alongside clinician-assessed response captured in routine care.
Ontada
Ontada, a division of McKesson, is an oncology data, research and technology company that is on a mission to transform cancer care. Our ownership of the leading oncology-specific electronic health record, iKnowMed, means we provide life sciences companies with data that reflects insights into physician behavior in near real-time, as the oncology standard of care changes. But what truly sets us apart is our deep-rooted connection to the largest community oncology network in the country, The U.S. Oncology Network, (The Network), which treats 1 in 5 cancer patients. This partnership is foundational to all our solutions. By leveraging this connection, we provide life sciences companies with diverse and representative data that reflects the care received in the community, where an estimated 85% of cancer patients seek care. It also allows us to provide our customers with clinical and research support from practicing oncologists for real-world research studies. Working directly with The Networks' oncologists and staff we provide life sciences with the opportunity to communicate important brand, clinical and product specific messages through our Ontada Learn offerings. Bolstered by McKesson's larger oncology ecosystem which includes the Sarah Cannon Research Institute, a leading oncology research organization and Genospace, a clinical trial matching technology, Ontada is well positioned to deliver actionable insights and drive innovation in the life sciences industry, ultimately contributing to the advancement of patient care in oncology.
